Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality.

Sluka SHM, Stämpfli SF, Akhmedov A, Klein-Rodewald T, Sanz-Moreno A, Horsch M, Grest P, Rothmeier AS, Rathkolb B, Schrewe A, Beckers J, Neff F, Wolf E, Camici GG, Fuchs H, Gailus-Durner V, Hrabě de Angelis M, Lüscher TF, Ruf W, Tanner FC.

Haematologica. 2019 Sep 5. pii: haematol.2019.218818. doi: 10.3324/haematol.2019.218818. [Epub ahead of print]

2.

Alternatively spliced tissue factor is not sufficient for embryonic development.

Sluka SH, Akhmedov A, Vogel J, Unruh D, Bogdanov VY, Camici GG, Lüscher TF, Ruf W, Tanner FC.

PLoS One. 2014 May 30;9(5):e97793. doi: 10.1371/journal.pone.0097793. eCollection 2014.

3.

Dronedarone reduces arterial thrombus formation.

Breitenstein A, Sluka SH, Akhmedov A, Stivala S, Steffel J, Camici GG, Riem HH, Beer HJ, Studt JD, Duru F, Luscher TF, Tanner FC.

Basic Res Cardiol. 2012 Nov;107(6):302. doi: 10.1007/s00395-012-0302-4. Epub 2012 Sep 29.

4.

Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice.

Rozenberg I, Sluka SH, Mocharla P, Hallenberg A, Rotzius P, Borén J, Kränkel N, Landmesser U, Borsig L, Lüscher TF, Eriksson EE, Tanner FC.

PLoS One. 2011;6(7):e21675. doi: 10.1371/journal.pone.0021675. Epub 2011 Jul 8.

5.

Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.

Rozenberg I, Sluka SH, Rohrer L, Hofmann J, Becher B, Akhmedov A, Soliz J, Mocharla P, Borén J, Johansen P, Steffel J, Watanabe T, Lüscher TF, Tanner FC.

Arterioscler Thromb Vasc Biol. 2010 May;30(5):923-30. doi: 10.1161/ATVBAHA.109.201079. Epub 2010 Mar 4.

PMID:
20203300

Supplemental Content

Loading ...
Support Center